Sign In
Buy VERU
$2.25
-0.100 (-4.26%)
At Close: Jun 03, 2026
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8
08:30am, Thursday, 01'st May 2025
MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and in
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
08:30am, Wednesday, 16'th Apr 2025
MIAMI, FL, April 16, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic
Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
08:30am, Monday, 31'st Mar 2025
MIAMI, FL, March 31, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic
Down -9.23% in 4 Weeks, Here's Why Veru (VERU) Looks Ripe for a Turnaround
10:35am, Thursday, 06'th Mar 2025
The heavy selling pressure might have exhausted for Veru (VERU) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in re
Veru Inc (VERU) Q1 2025 Earnings Call Transcript
02:35pm, Thursday, 13'th Feb 2025
Veru Inc (NASDAQ:VERU ) Q1 2025 Earnings Conference Call February 13, 2025 8:00 AM ET Company Participants Sam Fisch - Executive Director, Investor Relations and Corporate Communications. Mitchell Ste
Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress
06:30am, Thursday, 13'th Feb 2025
--Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as great
Veru Shares Tumble Despite Enobosarm's Lean Muscle Preservation Breakthrough
10:34am, Monday, 27'th Jan 2025
Veru Inc. VERU stock is plummeting on Monday after the company released topline results from the Phase 2b QUALITY clinical study of enobosarm for weight reduction.
-- Study met primary endpoint: Enobosarm treatment resulted in statistically significant reduction in the loss of lean mass in subjects receiving WEGOVY (p=0.002) -- -- Patients on Enobosarm on averag
What Makes Veru Inc. (VERU) a Strong Momentum Stock: Buy Now?
01:01pm, Thursday, 23'rd Jan 2025
Does Veru Inc. (VERU) have what it takes to be a top stock pick for momentum investors? Let's find out.
Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business
08:30am, Tuesday, 31'st Dec 2024
MIAMI, FL, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality
Veru Inc. (VERU) Reports Q4 Loss, Tops Revenue Estimates
08:01pm, Monday, 16'th Dec 2024
Veru Inc. (VERU) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.16 per share a year ago.
Veru to Present at the 17th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders
08:30am, Tuesday, 26'th Nov 2024
MIAMI, FL, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality
MIAMI, FL, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality
MIAMI, FL, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality
MIAMI, FL, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality
